Skip to main content

Jacinthe Leclerc

Professeure agrégée
Pharmacie
Pavillon Ferdinand-Vandry

jacinthe.leclerc@criucpq.ulaval.ca

Consulter l'ORCID de Jacinthe Leclerc

Domaine de recherche

  • Pharmacologie et sciences pharmaceutiques, n.c.a.
  • Épidémiologie (sauf l'épidémiologie nutritionnelle et vétérinaire)
  • Cardiologie et sciences circulatoires (y compris les maladies cardiovasculaires)
  • Traitement du langage naturel
  • Politiques en matière de la santé

  • Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (Reconnu FRQ - secteur santé)
  • Centre de recherche en données massives

Connaissance et perceptions des professionnels de la santé québécois à l'égard de la Loi de Vanessa

Programme: Réseaux thématiques de recherche

Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé

Type de financement: Subvention

Établissement tête: Université de Montréal

Du 1 April 2025 au 31 March 2027

Étude des problématiques associées à la sous-déclaration des événements indésirables (DECLARE)

Programme: Fonds des leaders John-R.-Evans (FLJR)

Organisme(s) subventionnaire(s): Plateforme informatique CRED, Ministère de la Santé et des Services sociaux, Fondation Canadienne pour l'innovation (La)

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 January 2024 au 20 November 2027

Dosing regimens safety of long-acting injectable antipsychotics: a research program

Organisme(s) subventionnaire(s): Fondation de l'Université Laval

Type de financement: Subvention

Établissement tête: Université Laval

Du 20 November 2023 au 31 December 2026

Rendre les soins pharmaceutiques plus sécuritaires en améliorant la DÉCLARation des Événements indésirables associés aux médicaments (DECLARE)

Programme: Chercheur-boursier Juniors 1 et 2, Seniors

Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 July 2022 au 30 June 2029

Rendre les soins pharmaceutiques plus sécuritaires en améliorant la DÉCLARation des Événements indésirables associés aux médicaments (DECLARE)

Programme: Établissement de jeunes chercheurs - Juniors 1

Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 July 2022 au 31 December 2028

Adverse events profile of longacting injectables antipsychotics: inputs from real-world data

Organisme(s) subventionnaire(s): Fondation de l'Université Laval

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 July 2023 au 31 December 2025

Have mRNA vaccines changed the biopharmacy of drugs? A pilot correlative study on the links between vaccination with mRNA vaccines and the incidence of acute infusion reactions in women with breast and ovarian cancer treated with

Programme: Réseaux thématiques de recherche

Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 April 2023 au 31 March 2025

Les événements indésirables graves sont-ils déclarés dans la population québécoise suivie pour insuffisance cardiaque?

Programme: Réseaux thématiques de recherche

Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 April 2023 au 31 March 2026

Produits de santé naturels, insuffisance cardiaque et événements indésirables : caractérisation des enjeux au sein du Registre panquébécois Vision C+

Programme: Projet pilote du FER

Organisme(s) subventionnaire(s): Fondation de l'Université Laval

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 January 2023 au 30 December 2024

Fonds de démarrage d'un nouveau professeur

Organisme(s) subventionnaire(s): Fondation de l'Université Laval

Type de financement: Subvention

Établissement tête: Université Laval

Du 1 July 2022 au 30 June 2026

  • Maude Lavallée, Doctorat en sciences pharmaceutiques

Encadrements terminés dans les 5 dernières années

  • Floraise Lynda Tanguenan, Maîtrise en sciences pharmaceutiques - avec mémoire
  • Sonia Corbin, Maîtrise en sciences pharmaceutiques - avec mémoire
  • Sarah O'Connor, Doctorat en sciences pharmaceutiques - pharmaco-épidémiologie

Publications des 5 dernières années

Diversity in Care Trajectories in Specialist Visits for Preventing Cardiovascular Events After New-Onset Diabetes: A Population-Based Cohort Study, Cjc Open, 2026. O'Connor, S., Blais, C., Sylvain-Morneau, J., Diop, A., Mésidor, M., Leclerc, J., Poirier, P.. DOI 10.1016/j.cjco.2026.05.006

Evolving Heart Failure Profiles in Quebec from 1998-2021: Insights from the Vision C+ Database, Cjc Open, 2026. Todkar, S., Marier-Tétrault, E., Turgeon, P.Y., Gélinas-Gascon, F., Couture, G., Després, P., Lortie, H., Basmadjian, L., Ahnadi, C.E., Ducharme, A., Lepage, S., Tournoux, F., Poirier, P., Leclerc, J.. DOI 10.1016/j.cjco.2026.04.011

Serious Adverse Events: A Replicability and Validation Study of Naranjo Causality Assessment Tool in a Canadian Clinical Setting, Journal of Evaluation in Clinical Practice, 2025. Pallavi Pradhan, Sonia Corbin, Shweta Todkar, Maude Lavallée, Isabelle Cloutier, Rosalie Darveau, Julie Méthot, Anick Bérard, Marie‐Eve Piché, Jacinthe Leclerc. DOI 10.1111/jep.70110

Causality assessment of adverse events by healthcare professionals in an academic hospital setting: a descriptive retrospective study, Canadian Journal of Physiology and Pharmacology, 2025. Corbin, S., Lavallée, M., Pradhan, P., Thibault, M., Méthot, J., Djiokeng, L.B.G., Bérard, A., Piché, M.-E., Gimenes, F.R.E., Darveau, R., Cloutier, I., Leclerc, J.. DOI 10.1139/cjpp-2024-0268

Medication Exposure and Mortality in Patients with Schizophrenia, JAMA Network Open, 2024. Brodeur, S., Chiu, Y.M., Courteau, J., Dorais, M., Oliver, D., Stip, E., Fleury, M.-J., Roy, M.-A., Vanasse, A., Lesage, A., Leclerc, J.. DOI 10.1001/jamanetworkopen.2024.47137

Underreporting of adverse events to health authorities by healthcare professionals: a red flag-raising descriptive study, International Journal for Quality in Health Care, 2024. Lavallee, M., Corbin, S., Pradhan, P., Guefack, L.B., Thibault, M., Methot, J., Berard, A., Piche, M.-E., Gimenes, F.R.E., Darveau, R., Cloutier, I., Leclerc, J.. DOI 10.1093/intqhc/mzae109

2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Journal of the American College of Cardiology, 2024. Thompson, A., Fleischmann, K.E., Smilowitz, N.R., de las Fuentes, L., Mukherjee, D., Aggarwal, N.R., Ahmad, F.S., Allen, R.B., Altin, S.E., Auerbach, A., Berger, J.S., Chow, B., Dakik, H.A., Eisenstein, E.L., Gerhard-Herman, M., Ghadimi, K., Kachulis, B., Leclerc, J., Lee, C.S., Macaulay, T.E., Mates, G., Merli, G.J., Parwani, P., Poole, J.E., Rich, M.W., Ruetzler, K., Stain, S.C., Sweitzer, B., Talbot, A.W., Vallabhajosyula, S., Whittle, J., Williams, K.A.. DOI 10.1016/j.jacc.2024.06.013

Polypharmacy and high-alert medications in patients with nasally placed feeding tube on admission and at hospital discharge: Multicenter cross-sectional study, Exploratory Research in Clinical and Social Pharmacy, 2024. Gimenes, F.R.E., Freitas, J.S.D., Koepp, J., Prado, P.R.D., Menezes, R.M., Leclerc, J., Medeiros, A.P.D., Teixeira, T.C.A., Carvalho, R.E.F.L.D., Zanetti, M.O.B., Miasso, A.I., Gonella, J.M.. DOI 10.1016/j.rcsop.2024.100474

Clinical Heart fAilure Management Program: Changing the practice by partnering primary care and specialists (CHAMP-HF), Ijc Heart and Vasculature, 2024. Parent, M., Leclerc, J., O'Meara, E., Barrette, R., Lévesque, S., Parent, M.-C., Brouillette, D., Garceau, P., Liszkowski, M., Rouleau, J., Ducharme, A.. DOI 10.1016/j.ijcha.2023.101330

Impact of Vanessa's Law on the Reporting of Serious Adverse Events: A Retrospective Study Among Antiplatelet Users in a Tertiary-Care Cardiology Centre, Cjc Open, 2024. Guefack Djiokeng, L.B., Todkar, S., Corbin, S., Lavallée, M., Pradhan, P., Thibault, M., Piché, M.-E., Méthot, J., Bérard, A., Gonella, J.M., Escobar Gimenes, F.R., Darveau, R., Cloutier, I., Leclerc, J.. DOI 10.1016/j.cjco.2024.09.003

Relationship Between Diet Quality and Statin Use Among Adults With Metabolic Syndrome From the CARTaGENE Cohort, Cjc Open, 2024. Bélanger, A., Desjardins, C., Leblay, L., Filiatrault, M., Barbier, O., Gangloff, A., Leclerc, J., Lefebvre, J., Zongo, A., Drouin-Chartier, J.-P.. DOI 10.1016/j.cjco.2023.09.014

2024 AHA/ACC/ACS/ASNC/HRS/SCA/ SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 2024. Thompson, A., Fleischmann, K.E., Smilowitz, N.R., de las Fuentes, L., Mukherjee, D., Aggarwal, N.R., Ahmad, F.S., Allen, R.B., Altin, S.E., Auerbach, A., Berger, J.S., Chow, B., Dakik, H.A., Eisenstein, E.L., Gerhard-Herman, M., Ghadimi, K., Kachulis, B., Leclerc, J., Lee, C.S., Macaulay, T.E., Mates, G., Merli, G.J., Parwani, P., Poole, J.E., Rich, M.W., Ruetzler, K., Stain, S.C., Sweitzer, B., Talbot, A.W., Vallabhajosyula, S., Whittle, J., Williams, K.A.. DOI 10.1161/CIR.0000000000001285

Relationship Between Diet Quality and Glucose-Lowering Medication Intensity Among Adults With Type 2 Diabetes: Results From the CARTaGENE Cohort, Cjc Open, 2024. Desjardins, C., Leblay, L., Bélanger, A., Filiatrault, M., Barbier, O., Guénette, L., Leclerc, J., Lefebvre, J., Zongo, A., Drouin-Chartier, J.-P.. DOI 10.1016/j.cjco.2023.09.015

Evolution of the burden of diabetes among adults and children in Québec, Canada, from 2001 to 2019: A population-based longitudinal surveillance study, Diabetes Epidemiology and Management, 2024. O'Connor, S., Robert, P., Leclerc, J., Poirier, P., Dubé, M., Trépanier, P.-L., Perron, L., Blais, C.. DOI 10.1016/j.deman.2023.100177

Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review, Advances in Nutrition, 2023. Desjardins, C., Cyrenne-Dussault, M., Barbier, O., Bélanger, A., Gangloff, A., Guénette, L., Leclerc, J., Lefebvre, J., Zongo, A., Drouin-Chartier, J.-P.. DOI 10.1016/j.advnut.2023.04.010

Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement from the American Heart Association, Circulation, 2023. Chow, S.L., Bozkurt, B., Baker, W.L., Bleske, B.E., Breathett, K., Fonarow, G.C., Greenberg, B., Khazanie, P., Leclerc, J., Morris, A.A., Reza, N., Yancy, C.W.. DOI 10.1161/CIR.0000000000001110

Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes, International Journal of Cardiology, 2023. Jarjour, M., Leclerc, J., Bouabdallaoui, N., Ahnadi, C., Brouillette, D., de Denus, S., Fortier, A., Garceau, P., Giraldeau, G., Lepage, S., Liszkowski, M., O'Meara, E., Parent, M.-C., Racine, N., Tremblay-Gravel, M., White, M., Rouleau, J.-L., Ducharme, A.. DOI 10.1016/j.ijcard.2022.09.058

Evolution in Trends of Primary Lower-Extremity Amputations Associated With Diabetes or Peripheral Artery Disease From 2006 to 2019, Canadian Journal of Cardiology, 2023. O'Connor, S., Blais, C., Leclerc, J., Sylvain-Morneau, J., Laouan Sidi, E.A., Hamel, D., Drudi, L., Gilbert, N., Poirier, P.. DOI 10.1016/j.cjca.2022.11.010

Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings, Journal of Applied Biomedicine, 2023. Pradhan, P., Lavallée, M., Akinola, S., Gimenes, F.R.E., Bérard, A., Méthot, J., Piché, M.-E., Gonella, J.M., Cloutier, L., Leclerc, J.. DOI 10.32725/jab.2023.010

Antipsychotic-Induced Metabolic Syndrome: A Review, Metabolic Syndrome and Related Disorders, 2023. Akinola, P.S., Tardif, I., Leclerc, J.. DOI 10.1089/met.2023.0003

Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review, Heliyon, 2022. Sarah O'Connor, Claudia Blais, Miceline Mésidor, Denis Talbot, Paul Poirier, Jacinthe Leclerc. DOI 10.1016/j.heliyon.2022.e10493

Programa de melhoria da qualidade na administração de medicamentos via sonda nasoenteral, Acta Paulista de Enfermagem, 2022. Laís Facioli Rosa Moreno da Costa, Carlos Alberto Grespan Bonacim, Rosana Aparecida Pereira, Jennifer Midiani Gonella, Jacinthe Leclerc, Fernanda Raphael Escobar Gimenes. DOI 10.37689/acta-ape/2022AO000934

Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review, BMJ Open, 2022. Carlotta Lunghi, Michèle Dugas, Jacinthe Leclerc, Elisabetta Poluzzi, Cathy Martineau, Valérie Carnovale, Théo Stéfan, Patrick Blouin, Johanie Lépine, Laura Jalbert, Nataly R Espinoza Suarez, Olha Svyntozelska, Marie-Pier Dery, Giraud Ekanmian, Daniele Maria Nogueira, Pelumi Samuel Akinola, Stéphane Turcotte, Becky Skidmore, Annie LeBlanc. DOI 10.1136/bmjopen-2022-062197

Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study, Drugs - Real World Outcomes, 2022. Maude Lavallée, Carolina Galli da Silveira, Samuel Akinola, Julie Méthot, Marie-Eve Piché, Anick Bérard, Magalie Thibault, Jennifer Midiani Gonella, Fernanda Raphael Escobar Gimenes, Jacinthe Leclerc. DOI 10.1007/s40801-021-00275-2

Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018, Clinicoeconomics and Outcomes Research, 2022. Villeneuve, T., Trudel, X., Gilbert-Ouimet, M., Leclerc, J., Milot, A., Sultan-Taïeb, H., Brisson, C., Guertin, J.R.. DOI 10.2147/CEOR.S340385

Acute care for patients exposed to a chemical attack: protocol for an international multicentric observational study, BMJ Open, 2022. Bourassa, S., Noebert, D., Dauphin, M., Rambaud, J., Kawaguchi, A., Léger, F., Beijer, D., Fortier, Y., Dligui, M., Ivanovski, H., Simard, S., Jouvet, P., Leclerc, J.. DOI 10.1136/bmjopen-2022-065015

Gaps in Prehospital Care for Patients Exposed to a Chemical Attack-A Systematic Review, Prehospital and Disaster Medicine, 2022. Bourassa, S., Paquette-Raynard, E., Noebert, D., Dauphin, M., Akinola, P.S., Marseilles, J., Jouvet, P., Leclerc, J.. DOI 10.1017/S1049023X22000401

Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, Medrxiv, 2022. Lunghi, C., Dugas, M., Leclerc, J., Poluzzi, E., Martineau, C., Carnovale, V., Stéfan, T., Blouin, P., Lépine, J., Jalbert, L., Espinoza Suarez, N.R., Svyntozelska, O., Dery, M.-P., Ekanmian, G., Nogueira, D.M., Akinola, P.S., Skidmore, B., LeBlanc, A.. DOI 10.1101/2022.02.17.22271152

Quality improvement program in medication administration through nasogastric tube, Acta Paulista De Enfermagem, 2022. da Costa, L.F.R.M., Bonacim, C.A.G., Pereira, R.A., Gonella, J.M., Leclerc, J., Gimenes, F.R.E.. DOI 10.37689/acta-ape/2022AO0009349

Corporate Lobbyists: Open Season on Academic Health Science?, Canadian Journal of Cardiology, 2021. Jacinthe Leclerc, Paul Poirier. DOI 10.1016/j.cjca.2020.04.033

Effect of bariatric surgery on blood pressure response to exercise in a severely obese population, Blood Pressure Monitoring, 2021. Sénéchal-Dumais, I., Auclair, A., Leclerc, J., Poirier, P.. DOI 10.1097/MBP.0000000000000543

Determinants of Cardiorespiratory Fitness After Bariatric Surgery: Insights From a Randomised Controlled Trial of a Supervised Training Program, Canadian Journal of Cardiology, 2021. Auclair, A., Harvey, J., Leclerc, J., Piché, M.-E., O'Connor, K., Nadreau, É., Pettigrew, M., Haykowsky, M.J., Marceau, S., Biertho, L., Hould, F.-S., Lebel, S., Biron, S., Julien, F., Bouvet, L., Lescelleur, O., Poirier, P.. DOI 10.1016/j.cjca.2020.03.032